ZIMMER BIOMET HOLDINGS, INC. (ZBH) Financials
Annual revenue, profitability and per-share results for ZIMMER BIOMET HOLDINGS, INC., as reported in SEC filings.
Revenue • FY2025
$8.23B
▲ 7.2%YoY
Net income • FY2025
$705.1M
▼ 22.0%YoY
Gross margin • FY2025
69.7%
Diluted EPS • FY2025
$3.55
▼ 19.9%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $8.23B | $705.1M | $5.74B | $3.55 | $1.47B | 13.3% | +7.2% |
| FY2024 | $7.68B | $903.8M | $5.49B | $4.43 | $1.3B | 16.7% | +3.9% |
| FY2023 | $7.39B | $1.02B | $5.31B | $4.88 | $1.29B | 17.3% | +6.6% |
| FY2022 | $6.94B | $231.4M | $4.92B | $1.10 | $1.17B | 10.0% | -11.4% |
Figures as reported in ZIMMER BIOMET HOLDINGS, INC.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a ZBH filing.
Get an email when ZBH files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.